20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Preliminary experience with ketone-targeted treatment of diabetic ketoacidosis

      abstract
      1 , , 1 , 1 , 1
      Critical Care
      BioMed Central
      32nd International Symposium on Intensive Care and Emergency Medicine
      20-23 March 2012

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction In May 2011 the Joint British Diabetes Societies (JBDS) published new guidance for managing adult diabetic ketoacidosis. We developed a JBDS-based protocol that measured and treated capillary ketonaemia (not blood glucose) hourly with i.v. 0.1 IU insulin/kg/hour increased by 1 IU/hour if the ketone reduction was <0.5 mM/hour. The final target was capillary ketonaemia <0.3 mM. To allow this insulin rate and avoid hypoglycaemia, 125 ml/hour of 10 or 20% dextrose was started when blood glucose was <14 mM (250 mg/dl). As the effects of this new protocol were unknown, all patients were managed in our high-dependency unit (HDU). We report our experience of the new protocol compared to our old 'sliding scale' insulin titration to blood glucose protocol. Methods We prospectively gathered results of the new protocol over 3 months and performed a chart review of the same results from patients admitted in the previous year managed on wards and the HDU. Results are expressed as median (range). Results Patients on the new protocol (n = 7) cleared ketones to <0.3 mM in 8 (7 to 20) hours. The insulin rate needed was 10 (6 to 17) IU/hour. Potassium during treatment was 4 (3.2 to 5.2) mM and required 35 (12 to 60) mM/hour to maintain the target 3.5 to 5 mM. No episodes of blood glucose <4 mM were recorded. Time to reach glucose <14 mM was 7 (1 to 15) hours with a fall rate of 3.7 (2.9 to 6.8) mM/hour. Patients on the old protocol (n = 39) were treated for 15 (5 to 20) hours with 3 (0.5 to 6) IU/hour. Potassium during treatment was 3.5 (2.8 to 5.5) mM and required 9 (6 to 16) mM/hour to maintain the target 3.5 to 5 mM. Time to reach glucose <14 mM was 3.5 (1 to 13) hours with a fall rate of 4.2 (0.3 to 13) mM/hour. A total 0.02 results per hour <4 mM were recorded in the old protocol. Conclusion The median insulin infusion rate in an individual patient and the range required to suppress capillary ketonaemia in all patients with diabetic ketoacidosis using this protocol was more than three times that in the old protocol and the amount of i.v. potassium required to maintain near-normal blood potassium during treatment was four times more. There was a slower correction of initial blood glucose. Blood glucose and potassium maintenance during treatment with this protocol would appear to require high-intensity nursing care to maintain patient safety.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: not found

          Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis.

          The Joint British Diabetes Societies guidelines for the management of diabetic ketoacidosis (these do not cover Hyperosmolar Hyperglycaemic Syndrome) are available in full at: (i) http://www.diabetes.org.uk/About_us/Our_Views/Care_recommendations/The-Management-of-Diabetic-Ketoacidosis-in-Adults; (ii)  http://www.diabetes.nhs.uk/publications_and_resources/reports_and_guidance; (iii) http://www.diabetologists-abcd.org.uk/JBDS_DKA_Management.pdf. This article summarizes the main changes from previous guidelines and discusses the rationale for the new recommendations. The key points are: Monitoring of the response to treatment (i) The method of choice for monitoring the response to treatment is bedside measurement of capillary blood ketones using a ketone meter. (ii) If blood ketone measurement is not available, venous pH and bicarbonate should be used in conjunction with bedside blood glucose monitoring to assess treatment response. (iii) Venous blood should be used rather than arterial (unless respiratory problems dictate otherwise) in blood gas analysers. (iv) Intermittent laboratory confirmation of pH, bicarbonate and electrolytes only. Insulin administration (i) Insulin should be infused intravenously at a weight-based fixed rate until the ketosis has resolved. (ii) When the blood glucose falls below 14 mmol/l, 10% glucose should be added to allow the fixed-rate insulin to be continued. (iii) If already taking, long-acting insulin analogues such as insulin glargine (Lantus(®), Sanofi Aventis, Guildford, Surry, UK) or insulin detemir (Levemir(®), Novo Nordisk, Crawley, West Sussex, UK.) should be continued in usual doses. Delivery of care (i) The diabetes specialist team should be involved as soon as possible. (ii) Patients should be nursed in areas where staff are experienced in the management of ketoacidosis. © 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.
            Bookmark

            Author and article information

            Conference
            Crit Care
            Crit Care
            Critical Care
            BioMed Central
            1364-8535
            1466-609X
            2012
            20 March 2012
            : 16
            : Suppl 1
            : P164
            Affiliations
            [1 ]Royal Bournemouth Hospital, Bournemouth, UK
            Article
            cc10771
            10.1186/cc10771
            3363582
            53ce6aca-a530-4c90-8e20-77eeb6491ec5
            Copyright ©2012 Riccio et al.; licensee BioMed Central Ltd.

            This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

            32nd International Symposium on Intensive Care and Emergency Medicine
            Brussels, Belgium
            20-23 March 2012
            History
            Categories
            Poster Presentation

            Emergency medicine & Trauma
            Emergency medicine & Trauma

            Comments

            Comment on this article